Breast cancers diagnosed in patients carrying a BRCA1 germline mutation display distinct histo-pathological as well as molecular characteristics and have been observed to differ from sporadic cases also regarding chemotherapeutic sensitivity [1]. The gene discussed is BRCA1; the disease is breast cancer.